HM4: The evolving clinical trial landscape

HM4_Panel

The European Clinical Trials Regulation (EU CTR) took effect on 31 January 2022. Since then, authorities, sites and sponsors have had to embrace the new Regulation to begin to successfully run clinical trials across the EU. Since 31 January 2023, all clinical trial applications (CTAs) must be submitted through the Clinical Trials Information System (CTIS) and since then, all stakeholders have been dealing with its updates, challenges, revisions and simplifications. In this panel we were fortunate to be able to hear from the different perspectives: EMA, European Commission, industry and consultancy.

How to read this journal article 

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.

Members login

Included with TOPRA membership

Already a TOPRA member?

Using your MyTOPRA credentials, log-in now for unlimited access to all Regulatory Rapporteur journal articles, online archive and the latest industry news and content.

Login

REGISTER FOR FREE

Free access to selected content

Register to continue to access industry news, podcasts and commentary plus one member-only journal article each month. You will still be able to view editorials and contents pages without restriction.

  • Create your own library to save your favourite content.
  • Sign up for Regulatory Rapporteur email newsletters.
Create a free account

JOIN TOPRA

TOPRA membership

Become a TOPRA member and join our global community of regulatory affairs professionals.

  • Great savings on our events and training.
  • Be part of our dynamic international community.
  • Contribute to the profession.
  • Grow your skills and knowledge.
  • Take your career to the next level.
Become a member